Restricted Access
This website is intended strictly for qualified research professionals. All products are sold for in-vitro laboratory research use only and are not intended for human or veterinary use.
Statements have not been evaluated by the U.S. Food and Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease. Janera Science is not a 503A compounding pharmacy or 503B outsourcing facility.
Date
Category
Batch traceability is the ability to connect a specific vial to the records of the run that produced it. It is what turns a certificate of analysis from a general reassurance into evidence about the material actually on a bench, and it rests on one thing being present: a lot number that matches.
This article covers what a lot number identifies, what a production record contains, why traceability is the difference between investigating a discrepancy and arguing about one, and how to test whether a supplier's documentation is genuinely traceable.
All Janera Science compounds are supplied strictly for in-vitro laboratory research use only. They are not intended for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any disease. The statements made on this website have not been evaluated by the U.S. Food and Drug Administration.
What a Lot Number Identifies
A lot number identifies a specific batch, and it is the field on a label that ties a physical vial to that batch's records. Everything else on the label describes the product line. FDA's drug manufacturing rules define it as the code from which a batch's complete history of manufacture, processing, packing, holding and distribution can be determined (21 CFR 210.3), and expect the lot number on a drug's label to yield that history (21 CFR 201.18).
The compound name tells a researcher what the material is supposed to be. The mass tells them how much is supposed to be in the vial. Neither distinguishes the vial in hand from an identical-looking vial that might have been filled months earlier from different starting material.
That distinction is the whole point. Two runs of the same compound are two separate batches. Each is synthesised and purified in its own run, and the two can carry different impurity profiles while both meeting the same release specification. A specification sets acceptance criteria, limits and ranges, not a single fingerprint (International Council for Harmonisation, 1999). The classes of impurity that vary between runs are set out in our guide to synthesis impurities.
Why product-level documentation cannot substitute
A document describing a product rather than a lot is describing an intention. It states what the compound is meant to be, which is information a researcher already had from the catalogue.
A document describing a lot is reporting a measurement. It states what one specific batch of material was found to be, on a stated date, by named methods.
The gap between those two is the reason a lot number without a matching document, or a document without a lot number, leaves a researcher exactly where they started.
What a Production Record Actually Contains
Pharmaceutical manufacturing has a defined answer to what traceability requires, and it is worth reading as a benchmark, because it shows what the concept means when taken seriously.
For drug products, federal regulation requires that "[b]atch production and control records shall be prepared for each batch of drug product produced and shall include complete information relating to the production and control of each batch" (21 CFR 211.188).
The record must document, among other things, the following, and each one closes a particular question:
Recorded | The question it answers later |
|---|---|
Dates for each significant step | When was this made, and in what order |
Identity of the major equipment and lines used | Which physical assets touched this material |
Batch identification of each component or in-process material used | What went in, and from which lot |
Weights and measures of components | What quantities were actually used |
In-process and laboratory control results | What was measured while it was being made |
Actual yield and percentage of theoretical yield | Did the run behave as expected |
Any sampling performed | What was taken for testing, and when |
Persons performing and directly supervising or checking each significant step | Who is accountable for each operation |
Any investigation made under § 211.192 | What went wrong, and what was concluded about it |
The component identification line is the one that makes traceability run both ways. Recording which lot of each component went into each batch (21 CFR 211.188), and logging each component shipment with the supplier's lot number where known (21 CFR 211.184), lets a finished lot be traced back to its raw-material lots, and each raw-material lot forward to the batches made with it.
What Traceability Makes Possible
The value of a record chain shows up when something is unexpected, which is precisely when nobody has time to build one.
An anomalous result becomes investigable. When an experiment produces an unexpected number, the material is one of the candidate explanations. Traceable documentation lets a researcher check what that specific lot was measured at. The alternative is reasoning about the compound in general, which cannot settle anything.
Two experiments become comparable. Work done three months apart used two vials. Whether those were the same lot is a question with a definite answer if lot numbers were recorded, and no answer at all if they were not. This is why recording the lot alongside the result is worth the two seconds it costs.
A problem can be bounded. If a defect is traced to a particular input, the record chain identifies every finished lot that used it. Without component-level records the only honest answer is that the scope is unknown.
A supplier's claims become checkable over time. A researcher holding lot numbers and their documents can compare what was reported across several batches. Consistency across runs is a different and stronger signal than any single certificate.
The part that depends on the researcher
Traceability is a shared responsibility, and the supplier only holds one half of it. A supplier can publish perfect lot-level documentation, and it does nothing if the lot number is never written down at the bench.
Recording the lot number alongside the experimental result is the habit that makes the rest usable. It costs nothing at the time and it is unrecoverable afterwards, because a vial that has been discarded takes its label with it.
Testing Whether Documentation Is Actually Traceable
Four checks separate real traceability from its appearance, and they apply to any supplier.
Does the certificate carry a lot number at all? A document without one cannot be traced to a specific batch. ICH Q7, the GMP guide for pharmaceutical ingredients, expects a certificate of analysis to state the batch number (International Council for Harmonisation, 2000); it is written for drug ingredients, but it is a sensible baseline. This is the most basic failure.
Does that number match the vial? A certificate for a different lot is documentation for someone else's material, however impressive it looks.
Is the document reachable without asking? Documentation available on request is documentation a buyer cannot check before deciding. Published lot-level records can be verified before an order, which is a materially different proposition.
Is there a document for every lot offered? A page listing lots where some carry certificates and others do not is showing the shape of the programme honestly. It is worth reading which is which.
Janera Science publishes lot-level certificates on the lab results page. Check that the lot on the certificate matches the lot on your vial. The fields inside the documents are explained in our guide to reading a certificate of analysis. The four tests behind each certificate are set out on our page covering how we test.
Frequently Asked Questions
What is a lot number?
The code that identifies a specific batch, from which its manufacturing history can be traced. It is the field on a vial label that distinguishes that batch from other batches of the same compound.
Why does a certificate need to be lot-specific?
Because two production runs of the same compound are separate batches, each synthesised and purified in its own run, and they can differ while both meeting the same specification. A certificate describing the product line reports an intention; one describing a lot reports a measurement.
What is recorded in a batch production record?
Under federal regulation for drug products, the record must document, among other things: dates, the major equipment and lines used, the batch identity of every component used, weights and measures, in-process and laboratory results, actual yield and percentage of theoretical yield, any sampling performed, the persons performing and checking each significant step, and any investigation made (21 CFR 211.188).
Do research use only suppliers have to keep batch records?
21 CFR Part 211 sets manufacturing requirements for drug products for administration to humans or animals (21 CFR 211.1). Under FDA regulations, intended use is judged by objective intent, including how a product is labeled and marketed, not only by a research use label (21 CFR 201.128). Whatever the regulatory position, lot-level records are what make traceability possible.
What should a researcher record at the bench?
The lot number, alongside the experimental result. It is the field that makes every later question answerable, and it cannot be recovered once the vial is gone.
What if a compound has no certificate published?
It means no document is available to check for that lot, and the honest reading is that the material is undocumented from a buyer's point of view until one exists. Where a compound is out of stock, Janera Science states that a new certificate will be published with the next batch.
Key Takeaways
A lot number identifies a specific batch, and it is the field on a label that connects a physical vial to that batch's records.
Two runs of the same compound are separate batches. They can carry different impurity profiles while both meeting the same release specification.
Batch production records for drug products must document, among other things, dates, equipment, the batch identity of every component, quantities, in-process results, yields, sampling, personnel and investigations (21 CFR 211.188). Component-level identity is what lets the chain run in both directions.
Traceability pays off when something is unexpected: it makes an anomalous result investigable, two experiments comparable, and the scope of a problem boundable.
Half the chain belongs to the researcher. A lot number not recorded at the bench cannot be recovered afterwards.
All Janera Science compounds are supplied strictly for in-vitro laboratory research use only. They are not intended for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any disease. The statements made on this website have not been evaluated by the U.S. Food and Drug Administration.
Review the Documentation
Every compound currently in stock is listed on the lab results page with a lot number and a linked certificate. Check that the lot on the certificate matches the lot on your vial.
